Esperion Therapeutics
American pharmaceutical company / From Wikipedia, the free encyclopedia
Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.
Quick Facts Company type, Traded as ...
Company type | Public |
---|---|
Nasdaq: ESPR Russell 2000 Component | |
Industry | Pharmaceutical |
Founded | 2008; 16 years ago (2008) |
Founder |
|
Headquarters | Ann Arbor, Michigan |
Key people | Sheldon Koenig (president and CEO) |
| |
Total assets |
|
Website | Esperion.com |
Footnotes / references financial information[2]: F-3, 4 |
Close